Skip to main content
Log in

International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgments

The researchers were not specifically funded to do this research. The GLOW study was financed through a grant from Warner Chilcott and Sanofi to the Center for Outcomes Research, University of Massachusetts, Worcester, MA.

Conflicts of interest

Stuart Silverman, Jeffrey Curtis, Kenneth Saag, Julie Flahive, Frederick Anderson, Roland Chapurlat, Christian Roux, JC Netelenbos, Johannes Pfeilschiffer, Nelson Watts, and Juliet Compston declare no conflict of interest. Jonathan Adachi declares that he is a consultant to Actavis, Amgen, Lilly, Merck, and Novartis and is doing clinical trials with Amgen, Lilly, Merck, and Novartis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Silverman.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silverman, S., Curtis, J., Saag, K. et al. International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporos Int 26, 419–420 (2015). https://doi.org/10.1007/s00198-014-2883-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-014-2883-2

Keywords

Navigation